FDA OKs clinical trial of COVID-19 survivor plasma

Apr 05, 2020 - Milwaukee Journal Sentinel (Wisconsin)

Federal regulators on Friday approved a clinical trial at Johns Hopkins University to test the use of plasma from recovered COVID-19 patients to treat doctors, nurses and other first responders who are at high risk of exposure to the new virus.

The news follows a nationwide effort by more than 100 researchers and at least 40 large hospitals to get clinical trials started using survivor plasma, a technique that has been used for more than a century to quell outbreaks of polio, measles, mump...

Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.

Are you ready to take your business development to the next level with RelSci Professional?

Nurture your network with daily alerts that notify you when your relationships make news

Map your relationships to any target or prospect to identify a warm introduction

Access unlimited deep dossiers on over 8 million decision makers

Best of all, you can try out all these powerful business development tools absolutely free for 30 days!

Check out News Home to stay on top of the people and organizations you care most about.